These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20397932)

  • 1. Is it time to treat HIV elite controllers with combined antiretroviral therapy?
    Torre D
    Clin Infect Dis; 2010 May; 50(10):1425; author reply 1425-6. PubMed ID: 20397932
    [No Abstract]   [Full Text] [Related]  

  • 2. CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
    Okulicz JF; Grandits GA; Weintrob AC; Landrum ML; Ganesan A; Crum-Cianflone NF; Agan BK; Marconi VC
    Clin Infect Dis; 2010 Apr; 50(8):1187-91. PubMed ID: 20218878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary HIV-1 infection: to treat or not to treat?
    Blankson JN
    AIDS Read; 2005 May; 15(5):245-6, 249-51. PubMed ID: 15900634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elite controllers as a model of functional cure.
    Autran B; Descours B; Avettand-Fenoel V; Rouzioux C
    Curr Opin HIV AIDS; 2011 May; 6(3):181-7. PubMed ID: 21460722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic syndrome with complex karyotype associated with long-term highly active antiretroviral therapy.
    Rieg S; Lübbert M; Kern WV; Timme S; Gärtner F; Rump JA
    Br J Haematol; 2009 Jun; 145(5):670-3. PubMed ID: 19344389
    [No Abstract]   [Full Text] [Related]  

  • 6. Honing the test-and-treat HIV strategy.
    Mastro TD; Cohen MS
    Science; 2010 May; 328(5981):976. PubMed ID: 20489007
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in antiretroviral therapy.
    Albrecht MA; Wilkin TJ; Coakley EP; Hammer SM
    Top HIV Med; 2003; 11(3):97-127. PubMed ID: 12837969
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute schizophrenic symptoms as the initial manifestation of HIV infection that respond to highly active antiretroviral therapy.
    Hashimoto T; Nishio M; Sakai T; Fujimoto K; Sato N; Endo T; Koike T
    Clin Infect Dis; 2006 Jun; 42(11):1653-5. PubMed ID: 16652326
    [No Abstract]   [Full Text] [Related]  

  • 11. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
    Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
    AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions of antiretroviral agents.
    Kosel BW; Aweeka F
    AIDS Clin Rev; 2000-2001; ():193-227. PubMed ID: 10999221
    [No Abstract]   [Full Text] [Related]  

  • 13. Nucleoside analogues and HIV: the combined cost to mitochondria.
    Cherry CL; Wesselingh SL
    J Antimicrob Chemother; 2003 May; 51(5):1091-3. PubMed ID: 12668570
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-resistant HIV.
    Laurence J
    AIDS Read; 2001 Aug; 11(8):384-5. PubMed ID: 11570260
    [No Abstract]   [Full Text] [Related]  

  • 15. Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.
    Rozera G; Abbate I; D'Offizi G; Corpolongo A; Narciso P; Vlassi C; Martini F; Calcaterra S; Capobianchi MR
    J Med Virol; 2007 Aug; 79(8):1047-54. PubMed ID: 17597482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiretroviral treatment of HIV infected patients].
    Lichterfeld M; Rockstroh JK
    Med Monatsschr Pharm; 2003 Apr; 26(4):111-21; quiz 121-2. PubMed ID: 12722525
    [No Abstract]   [Full Text] [Related]  

  • 18. The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult.
    Flanigan TP; Mitty JA
    Clin Infect Dis; 2006 Jun; 42(11):1636-8. PubMed ID: 16652322
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV agents. Overcoming barriers to a cure.
    TreatmentUpdate; 2005; 17(6):2-4. PubMed ID: 17228474
    [No Abstract]   [Full Text] [Related]  

  • 20. In for the long haul: debate paves way for long-term trials.
    Bass E
    Res Initiat Treat Action; 2001; 7(1):5-7. PubMed ID: 11548386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.